Literature DB >> 31420321

Response to Comment on "A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands".

Pouya Faridi1, Chen Li1,2, Sri H Ramarathinam1, Patricia T Illing1, Nicole A Mifsud1, Rochelle Ayala1, Jiangning Song1,3, Linden J Gearing4, Nathan P Croft5, Anthony W Purcell5.   

Abstract

This is our response to the Technical Comment by Rolfs et al. where we point out errors in their reanalysis of our data.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Mesh：

Substances：

Year:  2019        PMID： 31420321     DOI： 10.1126/sciimmunol.aaw8457

Source DB:  PubMed          Journal:  Sci Immunol        ISSN： 2470-9468


  12 in total

1.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

2.  Peptide-Spectrum Match Validation with Internal Standards (P-VIS): Internally-Controlled Validation of Mass Spectrometry-Based Peptide Identifications.

Authors:  Timothy Aaron Wiles; Laura M Saba; Thomas Delong
Journal:  J Proteome Res       Date:  2020-09-29       Impact factor: 4.466

Review 3.  Spliced HLA-bound peptides: a Black Swan event in immunology.

Authors:  P Faridi; M Dorvash; A W Purcell
Journal:  Clin Exp Immunol       Date:  2021-03-28       Impact factor: 4.330

4.  Database search engines and target database features impinge upon the identification of post-translationally cis-spliced peptides in HLA class I immunopeptidomes.

Authors:  Michele Mishto; Yehor Horokhovskyi; John A Cormican; Xiaoping Yang; Steven Lynham; Henning Urlaub; Juliane Liepe
Journal:  Proteomics       Date:  2022-03-03       Impact factor: 5.393

Review 5.  Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire.

Authors:  Sebastian P Haen; Markus W Löffler; Hans-Georg Rammensee; Peter Brossart
Journal:  Nat Rev Clin Oncol       Date:  2020-06-22       Impact factor: 66.675

6.  An in silico-in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.

Authors:  Michele Mishto; Artem Mansurkhodzhaev; Ge Ying; Aruna Bitra; Robert A Cordfunke; Sarah Henze; Debdas Paul; John Sidney; Henning Urlaub; Jacques Neefjes; Alessandro Sette; Dirk M Zajonc; Juliane Liepe
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

7.  Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.

Authors:  Yue A Qi; Tapan K Maity; Constance M Cultraro; Vikram Misra; Xu Zhang; Catherine Ade; Shaojian Gao; David Milewski; Khoa D Nguyen; Mohammad H Ebrahimabadi; Ken-Ichi Hanada; Javed Khan; Cenk Sahinalp; James C Yang; Udayan Guha
Journal:  Mol Cell Proteomics       Date:  2021-08-13       Impact factor: 5.911

8.  Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides.

Authors:  Alessia Melacarne; Valentina Ferrari; Luca Tiraboschi; Michele Mishto; Juliane Liepe; Marina Aralla; Laura Marconato; Michela Lizier; Chiara Pozzi; Offer Zeira; Giuseppe Penna; Maria Rescigno
Journal:  Cell Rep       Date:  2021-07-06       Impact factor: 9.423

9.  Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019.

Authors:  Anthony W Purcell
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

10.  Are There Indeed Spliced Peptides in the Immunopeptidome?

Authors:  Arie Admon
Journal:  Mol Cell Proteomics       Date:  2021-05-20       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.